Mark is the Chief Executive of both British Generic Manufacturers Association (BGMA) as well as its sister body the British Biosimilars Association (BBA). Mark’s career has spanned diverse experience across the life sciences sector. He is a former executive at Roche and co-founded the Medicines Discovery Catapult Ltd. He was the founding Managing Director of the government’s Office for Clinical Research Infrastructure – instrumental in managing the Department of Health’s £0.6 billion/year investment in research centres across the NHS. Mark served for seven years on the Chief Medical Officer for England’s strategy board for health research, and he has worked with Number 10 to contribute to the Prime Minister’s strategy for life sciences.
Mark Samuels
Mark is the Chief Executive of the British Generic Manufacturers Association.
